Artificial kidney market seen reaching $21.18 billion by 2030

The artificial kidney market is projected to rise from $11.43 billion in 2025 to $12.91 billion in 2026, then reach $21.18 billion by 2030, driven by growing chronic kidney disease cases, dialysis expansion and new device technologies. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - The artificial kidney market is tied to the growing need for kidney failure treatment and long-term renal care. - Rising demand for dialysis, home treatment options and portable devices could reshape how patients manage chronic kidney disease. - The market outlook points to broader adoption of technologies aimed at reducing dependence on in-center dialysis.

What happened: - The Business Research Company released a new artificial kidney market report on July 27, 2026. - The report projects the market will grow from $11.43 billion in 2025 to $12.91 billion in 2026. - The report forecasts the market will reach $21.18 billion by 2030. - The report identifies North America as the largest regional market in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period.

The details: - The report links recent growth to more end-stage renal disease cases, more dialysis centers and advances in dialysis membrane technology. - The report also cites wider adoption of home dialysis treatments and improved survival rates among kidney patients. - The report says future growth will be supported by investment in bioengineered kidney research. - The report points to rising demand for portable dialysis devices and remote patient monitoring. - The report highlights ongoing work on wearable dialysis systems, implantable artificial kidneys and smart monitoring in dialysis equipment. - The report says artificial kidneys are mechanical devices designed to replicate kidney function for people with end-stage renal disease or kidney failure. - Artificial kidneys operate outside the body and filter waste products from the bloodstream. - Artificial kidneys also help regulate calcium ion absorption in the digestive tract and support red blood cell production. - The report says chronic kidney disease is a key driver of demand. - Kidney Research UK reported in June 2023 that about 7.19 million people in the UK were living with CKD in 2023, or more than 10% of the population. - Kidney Research UK expects that figure to rise to 7.61 million by 2033. - The report says North America benefits from advanced healthcare infrastructure and high healthcare spending. - The report says Asia-Pacific growth is supported by higher healthcare investment, greater awareness of kidney disease and expanded access to dialysis. - The report also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in its regional outlook. - The report says its 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report offers a free sample and the full report.

Between the lines: - The forecast suggests the market is moving from standard dialysis toward more mobile and less disruptive treatment models. - The emphasis on bioengineered and implantable solutions points to a longer-term shift beyond conventional external dialysis equipment. - The regional split implies the largest installed market is in mature health systems, while the fastest growth is expected where access and investment are still expanding.

What's next: - The market’s next phase will likely center on device portability, remote monitoring and technologies that improve patient comfort and mobility. - Investment in artificial organ development and kidney research should continue to shape the competitive landscape through 2030. - Adoption will likely track broader CKD prevalence and expansion of dialysis infrastructure worldwide.